Company intelligence / Profile preview

VHealth Scientific

Minneapolis, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Vail Scientific develops cutting-edge solutions for early sepsis detection to enable enhanced patient outcomes and reduced mortality rates. The company emphasizes that with every hour of delay, sepsis patients' mortality increases by 8%, and as many as 80% of sepsis deaths could be avoided with rapid diagnosis and treatment.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Protein Biomarker Diagnostics

Partnerships

Minnetronix Medical (medical device development partner)Medical Alley (member)

Beyond the preview

Go deeper on VHealth Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VHealth Scientific.

Explore the full profile